MCID: ESN002
MIFTS: 41

Eosinophilia-Myalgia Syndrome malady

Rare diseases category

Aliases & Classifications for Eosinophilia-Myalgia Syndrome

About this section

Eosinophilia-Myalgia Syndrome, Aliases & Descriptions:

Name: Eosinophilia-Myalgia Syndrome 9 41 11 43 60
Ems 41 3
Syndrome with Inflammatory and Autoimmune Components That Affect the Skin, Fascia, Muscle, Nerve, Blood Vessels, Lung, and Heart 41
 
Severe Muscle Pain and Abnormally High Eosinophils 41
Eosinophilia Myalgia Syndrome 9
L-Tryptophan Induced Ems 41


Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Rare diseases


External Ids:

Disease Ontology9 DOID:998
MeSH33 D016603
SNOMED-CT55 95416007
ICD9CM27 710.5

Summaries for Eosinophilia-Myalgia Syndrome

About this section


CDC:3 Emergency medical services (EMS) workers are primary providers of pre-hospital emergency medical care and integral components of disaster response. The potentially hazardous job duties of EMS workers include lifting patients and equipment, treating patients with infectious illnesses, handling hazardous chemical and body substances, and participating in the emergency transport of patients in ground and air vehicles. These duties create an inherent risk for EMS worker occupational injuries and illnesses; and research has shown that they have high rates of fatal injuries and nonfatal injuries and illnesses.

MalaCards based summary: Eosinophilia-Myalgia Syndrome, also known as ems, is related to eosinophilia and eosinophilic fasciitis. An important gene associated with Eosinophilia-Myalgia Syndrome is IL5 (interleukin 5 (colony-stimulating factor, eosinophil)), and among its related pathways are Hematopoietic cell lineage and Calcineurin-regulated NFAT-dependent transcription in lymphocytes. The compounds toluene diisocyanate and dpa 1 have been mentioned in the context of this disorder. Affiliated tissues include skin, heart and lung.

Wikipedia:63 Eosinophilia?myalgia syndrome (EMS) is an incurable and sometimes fatal flu-like neurological condition... more...

Related Diseases for Eosinophilia-Myalgia Syndrome

About this section

Graphical network of the top 20 diseases related to Eosinophilia-Myalgia Syndrome:



Diseases related to eosinophilia-myalgia syndrome

Symptoms for Eosinophilia-Myalgia Syndrome

About this section

Drugs & Therapeutics for Eosinophilia-Myalgia Syndrome

About this section

Drug clinical trials:

Search ClinicalTrials for Eosinophilia-Myalgia Syndrome

Search NIH Clinical Center for Eosinophilia-Myalgia Syndrome

Genetic Tests for Eosinophilia-Myalgia Syndrome

About this section

Anatomical Context for Eosinophilia-Myalgia Syndrome

About this section

MalaCards organs/tissues related to Eosinophilia-Myalgia Syndrome:

31
Skin, Heart, Lung, Brain, Spinal cord, Skeletal muscle, Liver, T cells, Neutrophil

Animal Models for Eosinophilia-Myalgia Syndrome or affiliated genes

About this section

Publications for Eosinophilia-Myalgia Syndrome

About this section

Articles related to Eosinophilia-Myalgia Syndrome:

(show top 50)    (show all 335)
idTitleAuthorsYear
1
AHR activation by tryptophan--pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome? (19941898)
2010
2
Part II. Eosinophilia-Myalgia Syndrome: further correlations between compromised histamine degradation, eosinophilias and myopathies. (17806156)
2007
3
Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: a potential link between eosinophilia-myalgia syndrome and toxic oil syndrome. (17892268)
2007
4
Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome. (10606395)
1999
5
On-line HPLC-tandem mass spectrometry structural characterization of case-associated contaminants of L-tryptophan implicated with the onset of eosinophilia myalgia syndrome. (9817085)
1998
6
Increased activity of the alpha 1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndrome. (9076948)
1997
7
The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels. (8906286)
1996
8
1995 Bailey K. Ashford lecture. Public health lessons from two catastrophic epidemics: the toxic oil syndrome and the eosinophilia-myalgia syndrome. (8744866)
1996
9
1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro. (8624499)
1995
10
Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. (8579979)
1995
11
Eosinophilia-myalgia syndrome: a long-term follow-up study. (7660215)
1995
12
P-31 magnetic resonance spectroscopy of skeletal muscle in the eosinophilia-myalgia syndrome: a preliminary study. (8035389)
1994
13
Pharmacogenetic characteristics of the eosinophilia-myalgia syndrome. (7955801)
1994
14
The eosinophilia-myalgia syndrome: lessons from Germany. (8015338)
1994
15
Studies with 1,1'-ethylidenebis(tryptophan), a contaminant associated with L-tryptophan implicated in the eosinophilia-myalgia syndrome. (8184420)
1994
16
Eosinophilia myalgia syndrome: absence of immunoglobulin reactivity suggests a cellular rather than humoral mechanism. (7976226)
1994
17
Eosinophilia-myalgia syndrome in Germany: an epidemiologic review. (8015323)
1994
18
Production of polyclonal antibodies against 1,1'-ethyliden bis[L-tryptophan] (EBT), a potential contaminant causing eosinophilia-myalgia syndrome (EMS). (8475503)
1993
19
Eosinophilia-myalgia syndrome and fasciitis with an active alveolitis. (8355447)
1993
20
Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report. (8266108)
1993
21
The eosinophilia-myalgia syndrome: current concepts and future directions. (1551286)
1992
22
Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. (1386918)
1992
23
Central nervous system involvement in the eosinophilia-myalgia syndrome. (1417516)
1992
24
A histopathologic comparison of Shulman's syndrome (diffuse fasciitis with eosinophilia) and the fasciitis associated with the eosinophilia-myalgia syndrome. (1732344)
1992
25
Identification of decomposition products of 1,1'-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome. (1504513)
1992
26
Episodic angioedema with eosinophilia versus eosinophilia-myalgia syndrome. (1583248)
1992
27
Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome. (1534836)
1992
28
Eosinophilia-myalgia syndrome: the aftermath. (1523446)
1992
29
Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. (1929872)
1991
30
Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndrome. (2068062)
1991
31
Eosinophilia-myalgia syndrome: the Cleveland Clinic experience. (1934454)
1991
32
Eosinophilia-myalgia syndrome associated with L-tryptophan use. (1984598)
1991
33
L-tryptophan-induced eosinophilia-myalgia syndrome. (1829754)
1991
34
Postmortem studies of the heart in three fatal cases of the eosinophilia-myalgia syndrome. (2058857)
1991
35
Unraveling the eosinophilia-myalgia syndrome. (1863082)
1991
36
Eosinophilia-myalgia syndrome. A clinical case series of 21 patients. New Mexico Eosinophilia-Myalgia Syndrome Study Group. (2001136)
1991
37
Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease. (2273104)
1990
38
Dermal mucinosis in the eosinophilia-myalgia syndrome. (2241211)
1990
39
The eosinophilia-myalgia syndrome. (2339858)
1990
40
Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome. (2164712)
1990
41
Eosinophilia-myalgia syndrome: unresolved questions. (2372919)
1990
42
Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. (2162498)
1990
43
L-tryptophan induced eosinophilia-myalgia syndrome. (2273498)
1990
44
Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome. (2166897)
1990
45
Eosinophilia-myalgia syndrome. Results of national surveillance. (2398610)
1990
46
The eosinophilia-myalgia syndrome with neuritis associated with L-tryptophan use. (2339856)
1990
47
Update: eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan--United States, as of January 9, 1990. (2104651)
1990
48
Eosinophilia-myalgia syndrome with myoclonic jerks. (2292676)
1990
49
The eosinophilia-myalgia syndrome. (2139551)
1990
50
Eosinophilia-myalgia syndrome--New Mexico. (2509886)
1989

Variations for Eosinophilia-Myalgia Syndrome

About this section

Expression for genes affiliated with Eosinophilia-Myalgia Syndrome

About this section
Search GEO for disease gene expression data for Eosinophilia-Myalgia Syndrome.

Pathways for genes affiliated with Eosinophilia-Myalgia Syndrome

About this section

Pathways related to Eosinophilia-Myalgia Syndrome according to GeneCards Suite gene sharing:

(show all 24)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.6IL5, HLA-DRB1
2
Show member pathways
Calcium signaling in the CD4+ TCR pathway36
9.5IL5, IFNG
39.5IL5, IFNG
49.5IFNG, IL5
59.5IFNG, IL5
69.5IFNG, IL5
7
Show member pathways
9.5HLA-DQA1, HLA-DRB1
89.5HLA-DRB1, HLA-DQA1
9
Show member pathways
Immune response IL 22 signaling pathway58
G protein signaling N RAS regulation pathway58
9.5HLA-DRB1, HLA-DQA1
10
Show member pathways
9.5HLA-DRB1, HLA-DQA1
119.5HLA-DRB1, HLA-DQA1
129.4IFNG, IDO1
13
Show member pathways
Immune response IL 12 induced IFN gamma production58
9.3IFNG, HLA-DRB1
149.3IFNG, HLA-DRB1
159.0IL5, IFNG, HLA-DRB1
16
Show member pathways
8.9HLA-DQA1, HLA-DRB1, IFNG
178.9HLA-DQA1, HLA-DRB1, IFNG
18
Show member pathways
8.9IFNG, HLA-DRB1, HLA-DQA1
198.9IFNG, HLA-DRB1, HLA-DQA1
20
Show member pathways
8.9IFNG, HLA-DRB1, HLA-DQA1
218.9IFNG, HLA-DRB1, HLA-DQA1
22
Show member pathways
8.5IL5, IFNG, HLA-DRB1, HLA-DQA1
23
Show member pathways
8.5IL5, IFNG, HLA-DRB1, HLA-DQA1
24
Show member pathways
8.5HLA-DQA1, HLA-DRB1, IFNG, IL5

Compounds for genes affiliated with Eosinophilia-Myalgia Syndrome

About this section

Compounds related to Eosinophilia-Myalgia Syndrome according to GeneCards Suite gene sharing:

(show all 40)
idCompoundScoreTop Affiliating Genes
1toluene diisocyanate4310.2HNMT, IL5
2dpa 1439.9HLA-DQA1, HLA-DRB1
3pirfenidone43 5910.9IL5, IFNG
4amphotericin b439.9IL5, IFNG
5lapatinib43 49 1211.9HLA-DQA1, HLA-DRB1
6il-12439.9IFNG, IL5
7imiquimod43 59 28 1212.9IL5, IFNG
81-methyltryptophan439.9IDO1, IFNG
9con a439.9IL5, IFNG
103-hydroxyanthranilic acid43 2410.8IDO1, IFNG
11gm-csf43 2810.8IL5, IFNG
12kynurenine439.8IFNG, IDO1
13budesonide43 49 1211.8IFNG, IL5
14fluticasone propionate43 49 59 1212.8IL5, IFNG
15indoleamine439.8IFNG, IDO1
16polyinosinic-polycytidylic acid439.8IFNG, IL5
17rolipram43 59 2811.8IL5, IFNG
18methylcellulose439.8IFNG, IL5
19il 10439.8IL5, IFNG
20s-nitroso-n-acetylpenicillamine439.8IFNG, IDO1
212,5-oligoadenylate439.7IDO1, IFNG
22anti-fungal439.7IFNG, IL5
23gold sodium thiomalate439.7HLA-DRB1, IFNG
24tarc439.7IFNG, IL5
25l-nmma439.7IFNG, IDO1
26glucosamine43 24 1211.6IFNG, IL5
27infliximab43 49 1211.6IDO1, IFNG
28ivig439.6IFNG, IL5
29l-tryptophan49 28 43 24 1213.5IDO1, IFNG, IL5
30poly(i-c)439.5IL5, IFNG, IDO1
31thalidomide43 49 59 1212.5IL5, IFNG
32histamine43 28 2411.5IFNG, IL5, HNMT
33rantes439.5IL5, IFNG, IDO1
34glatiramer acetate43 1210.4IL5, IFNG, HLA-DRB1
35allergens439.4IL5, IFNG, HLA-DRB1
36neopterin439.3IDO1, IFNG
37pge2439.3IL5, IFNG, IDO1
38thymidine43 2410.1IL5, IFNG, IDO1
39cycloheximide438.8IL5, IFNG, IDO1
40arginine438.5HLA-DQA1, HLA-DRB1, IDO1, IFNG, IL5

GO Terms for genes affiliated with Eosinophilia-Myalgia Syndrome

About this section

Cellular components related to Eosinophilia-Myalgia Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:00426139.6HLA-DRB1, HLA-DQA1
2integral component of lumenal side of endoplasmic reticulum membraneGO:00715569.6HLA-DRB1, HLA-DQA1
3clathrin-coated endocytic vesicle membraneGO:00306699.6HLA-DRB1, HLA-DQA1
4transport vesicle membraneGO:00306589.5HLA-DQA1, HLA-DRB1
5endocytic vesicle membraneGO:00306669.5HLA-DRB1, HLA-DQA1
6ER to Golgi transport vesicle membraneGO:00125079.4HLA-DRB1, HLA-DQA1
7trans-Golgi network membraneGO:00325889.2HLA-DRB1, HLA-DQA1

Biological processes related to Eosinophilia-Myalgia Syndrome according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of interleukin-12 productionGO:00327359.5IFNG, IDO1
2antigen processing and presentation of exogenous peptide antigen via MHC class IIGO:00198869.5HLA-DRB1, HLA-DQA1
3T cell costimulationGO:00312959.4HLA-DRB1, HLA-DQA1
4T cell receptor signaling pathwayGO:00508529.2HLA-DRB1, HLA-DQA1
5immune responseGO:00069559.2HLA-DQA1, HLA-DRB1, IL5
6interferon-gamma-mediated signaling pathwayGO:00603339.0HLA-DQA1, HLA-DRB1, IFNG
7cytokine-mediated signaling pathwayGO:00192218.7IL5, IFNG, HLA-DRB1, HLA-DQA1

Molecular functions related to Eosinophilia-Myalgia Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II receptor activityGO:00323959.5HLA-DRB1, HLA-DQA1

Products for genes affiliated with Eosinophilia-Myalgia Syndrome

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Eosinophilia-Myalgia Syndrome

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet